Loading...
Market
Will Sanofi's Beijing insulin facility be operational by mid-2026?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Sanofi's official press release or industry reports
Story
Sanofi to Invest €1 Billion ($1.05 Billion) in Largest Single Investment for Beijing Insulin Production
Dec 2, 2024, 04:39 PM
Sanofi, the French pharmaceutical company, has announced plans to invest approximately 1 billion euros ($1.05 billion) to establish a new insulin production facility in Beijing. This investment marks Sanofi's largest single investment in China to date. The announcement follows a meeting between China's Commerce Minister Wang Wentao and Sanofi's Chairman Frédéric Oudéa, where Wang emphasized China's commitment to providing a favorable business environment for pharmaceutical companies. This development comes amid ongoing trade tensions between China and the European Union, highlighting Sanofi's strategic move to strengthen its presence in the Chinese market.
View original story
Similar markets
No • 50%
Yes • 50%
Construction completed • 25%
Production started • 25%
None of the above • 25%
Construction started • 25%
Not operational • 25%
Fully operational • 25%
Partially operational • 25%
Other • 25%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No significant change • 25%
Increase by over 10% • 25%
Increase by 5-10% • 25%
Increase by less than 5% • 25%
Project delayed • 25%
Project halted • 25%
Project unaffected • 25%
Project expedited • 25%